These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17210130)

  • 1. Physical dissection of the CCAAT/enhancer-binding protein alpha in regulating the mouse amelogenin gene.
    Xu Y; Zhou YL; Erickson RL; Macdougald OA; Snead ML
    Biochem Biophys Res Commun; 2007 Mar; 354(1):56-61. PubMed ID: 17210130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional antagonism between Msx2 and CCAAT/enhancer-binding protein alpha in regulating the mouse amelogenin gene expression is mediated by protein-protein interaction.
    Zhou YL; Lei Y; Snead ML
    J Biol Chem; 2000 Sep; 275(37):29066-75. PubMed ID: 10859305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-Y and CCAAT/enhancer-binding protein alpha synergistically activate the mouse amelogenin gene.
    Xu Y; Zhou YL; Luo W; Zhu QS; Levy D; MacDougald OA; Snead ML
    J Biol Chem; 2006 Jun; 281(23):16090-8. PubMed ID: 16595692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factor sumoylation and factor YY1 serve to modulate mouse amelogenin gene expression.
    Xu Y; Zhou YL; Ann DK; MacDougald OA; Shum L; Snead ML
    Eur J Oral Sci; 2006 May; 114 Suppl 1():169-77; discussion 201-2, 381. PubMed ID: 16674681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of CCAAT/enhancer-binding protein alpha as a transactivator of the mouse amelogenin gene.
    Zhou YL; Snead ML
    J Biol Chem; 2000 Apr; 275(16):12273-80. PubMed ID: 10766866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p300 coactivates the adipogenic transcription factor CCAAT/enhancer-binding protein alpha.
    Erickson RL; Hemati N; Ross SE; MacDougald OA
    J Biol Chem; 2001 May; 276(19):16348-55. PubMed ID: 11340085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCAAT/enhancer-binding protein delta (C/EBPdelta) maintains amelogenin expression in the absence of C/EBPalpha in vivo.
    Xu Y; Zhou YL; Gonzalez FJ; Snead ML
    J Biol Chem; 2007 Oct; 282(41):29882-9. PubMed ID: 17704518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumour necrosis factor-alpha-mediated suppression of the CCAAT/enhancer binding protein-alpha gene transcription in hepatocytes involves inhibition of autoregulation.
    Foka P; Singh NN; Salter RC; Ramji DP
    Int J Biochem Cell Biol; 2009 May; 41(5):1189-97. PubMed ID: 19027873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
    Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
    Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C/EBPalpha and HNF6 protein complex formation stimulates HNF6-dependent transcription by CBP coactivator recruitment in HepG2 cells.
    Yoshida Y; Hughes DE; Rausa FM; Kim IM; Tan Y; Darlington GJ; Costa RH
    Hepatology; 2006 Feb; 43(2):276-86. PubMed ID: 16440369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and dexamethasone induce GLUT4 gene expression in foetal brown adipocytes: synergistic effect through CCAAT/enhancer-binding protein alpha.
    Hernandez R; Teruel T; Lorenzo M
    Biochem J; 2003 Jun; 372(Pt 2):617-24. PubMed ID: 12641495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma.
    Zeng C; Wang R; Li D; Lin XJ; Wei QK; Yuan Y; Wang Q; Chen W; Zhuang SM
    Hepatology; 2010 Nov; 52(5):1702-12. PubMed ID: 21038412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C/EBPalpha activates the transcription of triacylglycerol hydrolase in 3T3-L1 adipocytes.
    Wei E; Lehner R; Vance DE
    Biochem J; 2005 Jun; 388(Pt 3):959-66. PubMed ID: 15752068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A positive regulatory domain in CCAAT/enhancer binding protein β (C/EBPΒ) is required for the glucocorticoid-mediated displacement of histone deacetylase 1 (HDAC1) from the C/ebpα promoter and maximum adipogenesis.
    Abdou HS; Atlas E; Haché RJ
    Endocrinology; 2013 Apr; 154(4):1454-64. PubMed ID: 23456364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the promoter region of the rat CCAAT/enhancer-binding protein alpha gene and regulation by thyroid hormone in rat immortalized brown adipocytes.
    Menéndez-Hurtado A; Santos A; Pérez-Castillo A
    Endocrinology; 2000 Nov; 141(11):4164-70. PubMed ID: 11089549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C/EBPα mediates the transcriptional suppression of human calreticulin gene expression by TNFα.
    Vig S; Pandey AK; Verma G; Datta M
    Int J Biochem Cell Biol; 2012 Jan; 44(1):113-22. PubMed ID: 22024156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCAAT/enhancer binding protein alpha uses distinct domains to prolong pituitary cells in the growth 1 and DNA synthesis phases of the cell cycle.
    Liu W; Enwright JF; Hyun W; Day RN; Schaufele F
    BMC Cell Biol; 2002 Mar; 3():6. PubMed ID: 11914124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human liver fatty acid binding protein (hFABP1) gene is regulated by liver-enriched transcription factors HNF3β and C/EBPα.
    Wu YL; Peng XE; Wang D; Chen WN; Lin X
    Biochimie; 2012 Feb; 94(2):384-92. PubMed ID: 21856370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.
    Asou H; Gombart AF; Takeuchi S; Tanaka H; Tanioka M; Matsui H; Kimura A; Inaba T; Koeffler HP
    Genes Chromosomes Cancer; 2003 Feb; 36(2):167-74. PubMed ID: 12508245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.